TRB-061

TypeInjection StagePhase 1 Latest updateMay 2, 2025Phase 1 study started

What stands out

Injection every 4 weeks in trials

Derived from NCT06934252 ·

4 US eczema labels

(Dupixent, Ebglyss, Nemluvio, Adbry)

· This is a summary of public records for informational purposes only. It is not medical advice.

History

Earliest recorded event: May 2, 2025. This timeline shows events collected by Eczema Radar and may not include the treatment’s full history. Study details reflect the latest registry record available here.

May 2, 2025Phase 1 trial startedPhase 1a/1b Study of TRB-061 in Healthy Participants & Patients With Atopic Dermatitis ClinicalTrials.gov NCT06934252

Sources

Trials

NCT06934252